SHARE:  
November 8, 2021
Gastric Cancer Registry Makes Strides Towards Major Data Expansion
Gesundheit Superfoods: Leafy Greens

Chef Hans Rueffert is an expert in sneaking in nutrient-dense nutrition and dark leafy greens are no exception! With so many to pick from, you're bound to find a few delicious options to incorporate into this warm leafy green salad.
The Gesundheit Kitchen LIVE
Join Chef Hans for a Special Pre-Holiday Gathering

Thursday, November 18th
12pm PST/3pm EST

Streaming at gastriccancer.org and Facebook.
Research Roundup
Drug developers reported several recent advances during the 2021 European Society for Medical Oncology(ESMO) World Congress on Gastrointestinal Cancer. 

Daiichi Sankyo presented data showing that its drug Enhertu produced a clinically meaningful benefit in a study of patients with HER2-positive and HER2-low gastric cancer. 

Combining Abraxane (paclitaxel) with a novel drug that inhibits the PI3K pathway showed anti-tumor activity in a small trial of patients with PTEN-deficient gastric cancer. 

Combining ALX Oncology Holdings’ experimental drug ALX148, a CD47 blocker, with Herceptin and chemotherapy produced a 72% response rate in a trial of patients with HER2-positive gastric cancer. 
Quick Links to Resources
Special Thanks to Our
National Sustaining Sponsors
Spread the word. Share the Gastric Cancer Foundation Newsletter.